Novartis Pharma Submits Improvement Plan, Notifies of Over 2,500 Unreported Serious ADRs

September 1, 2014
Novartis Pharma K.K. said on August 28 that it has submitted to the health minister a business improvement plan and information on 2,579 serious adverse drug reactions (ADRs), which were possibly caused by the company’s drugs but had not been...read more